Company news
Optimizerx Corporation (NASDAQ:OPRX) news
Every Optimizerx Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12, 2026
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
July 29, 2026
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
July 23, 2026
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 25, 2026
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 21, 2026
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
May 12, 2026
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
May 11, 2026
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
April 29, 2026
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
April 28, 2026
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
April 8, 2026
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
February 5, 2026
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
January 7, 2026
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
December 17, 2025
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
November 6, 2025
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
October 20, 2025
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
September 10, 2025
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
September 9, 2025
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
August 19, 2025
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
August 7, 2025
Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors
July 30, 2025
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
July 17, 2025
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
June 24, 2025
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
June 18, 2025
OptimizeRx to Participate in Upcoming Investor Conferences
May 16, 2025
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
May 12, 2025
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
May 1, 2025
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
April 23, 2025
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
April 18, 2025
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
March 11, 2025
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
March 10, 2025
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
February 27, 2025
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
December 23, 2024
OptimizeRx Reports Third Quarter 2024 Financial Results
November 13, 2024
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
October 31, 2024
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Comm...
September 10, 2024
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
September 9, 2024
OptimizeRx Reports Second Quarter 2024 Financial Results
August 8, 2024
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Val...
June 20, 2024
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
OptimizeRx to Participate in Upcoming Investor Conferences
May 6, 2024
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024